Dear Friend,

For the first time in its history, the FDA has laid out a plan to phase out animal-testing in drug development.

It’s a seismic shift—one that could save millions of animals from needless suffering while also improving human health outcomes. And we want you to be part of the conversation.

Join us this Thursday evening for a virtual town hall hosted by Animal Wellness Action and the Center for a Humane Economy. We’ll explore the FDA’s groundbreaking announcement, what it means for animals and patients alike, and how we can keep the pressure on to accelerate this humane transformation.

A SEISMIC SHIFT AT THE FDA
Why the Phaseout of Animal-Testing for Pharmaceuticals May Be at Hand
Thursday, April 17, 2025, at 8 p.m. ET

You'll receive a link for the online event after completing your registration. Hosted by the Center for a Humane Economy and the Claudia Miller Ignite Series on Animal Welfare

✅ What You'll Learn

• How the FDA Modernization Acts 2.0 and 3.0 triggered a rewrite of the rules of drug testing
• What Dr. Makary's commitment to phasing out animal testing means for science and ethics, the future of drug development and pricing, and expansion of new drugs for rare diseases
• How you've helped fuel one of the most important regulatory reforms in decades
• What's next—and how you can help keep the pressure on

✅ Why It Matters
Since 1938, the law has required drugs to be tested on animals—dogs, monkeys, mice, and more—before human trials could begin. But those tests have always been a poor proxy for human biology. The result? A shocking 95% of drugs that pass animal tests end up failing in human trials.

Now, thanks to sustained pressure from advocates with the Center for a Humane Economy, Congress passed the FDA Modernization Act 2.0, which gives drug developers the option to use cutting-edge, animal-free methods instead—tools like organ-on-a-chip technology, computer modeling, and 3D bioprinting. These methods are not only more humane but also cheaper, faster, and more reliable.

In response, new FDA Commissioner Dr. Marty Makary has declared a new era—one where animal tests will soon be the exception, not the rule. He’s promised incentives for drug developers to adopt modern, non-animal approaches.

That means:

✔️ Sparing millions of animals
✔️ Lower-cost, safer drugs
✔️ Faster approval of treatments and cures

Hear directly from animal-advocates, scientists, and tech leaders about this historic transformation in drug development, with the agency shedding the use of beagles, primates, and other animals in favor of 21st-century non-animal testing methods.

Our organizations—the Center for a Humane Economy and Animal Wellness Action—have worked for years to get to this moment. But to ensure progress doesn’t stall, we need informed advocates like you at the table.

Register now to be part of this timely and hopeful discussion. Help us turn this FDA pledge into a lasting legacy. Hosted by the Center for a Humane Economy and the Claudia Miller Ignite Series on Animal Welfare.

For the animals and for a better future,